Q4 2018 Investor Presentation

Focus on Operating Excellence is Driving Improved Operating Leverage Operating 24.6% Profit $2,500 25.9% $2,340 13% $2,067 $2,000 $1,500 $1,000 19% $500 $508 © 2018 ResMed | Q4 2018 Investor Presentation | 34 FY2017 ■Non-GAAP Operating Income ■Revenue $607 FY2018 ResMed

View entire presentation